Chest
Volume 121, Issue 6, June 2002, Pages 1977-1987
Journal home page for Chest

Reviews
The Role of Anticholinergics in Acute Asthma Treatment: An Evidence-Based Evaluation

https://doi.org/10.1378/chest.121.6.1977Get rights and content

The role for anticholinergic medications in acute asthma is not well-defined. Thus, the use of therapy with anticholinergics and β2-agonists, either simultaneously or in sequence, has produced positive as well as negative results in trials. Therefore, the current recommendations for the use of these drugs in the emergency department (ED) and hospital management of asthma exacerbations are not precise. This review answers the following question: what level of evidence is available in the literature to support the use of anticholinergic medications in combination with β2-agonists in acute asthma patients? We limited the search on our therapy question to systematic reviews of randomized trials and/or randomized controlled trials not included in the reviews. After an extensive review of the most relevant evidence, the following conclusions may be emphasized. (1) The use of multiple doses of ipratropium bromide are indicated in the ED treatment of children and adults with severe acute asthma. The studies reported a substantial reduction in hospital admissions (30 to 60%; number needed to treat, 5 to 11) and significant differences in lung function favoring the combined treatment. No apparent increase in the occurrence of side effects was observed. (2) The use of single-dose protocols of ipratropium bromide with β2-agonist treatment produced, particularly in children with more severe acute asthma, a modest improvement in pulmonary function without reduction in hospital admissions; in adults, the data showed a similar increase in pulmonary function with an approximately 35% reduction in the hospital admission rate. In patients with mild-to-moderate acute asthma, there is no apparent benefit from adding a single dose of an anticholinergic medication.

Section snippets

Materials and Methods

The studies found were evaluated based on the following ranking for level of evidence59: The best level (level I) included results from large, randomized, controlled trials or systematic reviews of randomized trials. The next level of evidence (level II) would be small, randomized, clinical trials that have insufficient numbers of patients to achieve statistically significant results. Finally, cohort (level III), case control (level IV), and case series (level V) would be considered lower

Pediatric Studies

The search of the previously described databases produced two systematic reviews about the efficacy of ipratropium bromide and anticholinergic agent use in children with acute asthma.

In the review by Osmond and Klassen,65 six randomized controlled trials (285 patients) involving pediatric and adolescent patients (age range, 1 to 17 years) with acute asthma were examined to determine the effect of treatment (ie, ipratropium bromide plus β-agonists vs β-agonists alone) on clinical and physiologic

References (75)

  • RY Lin et al.

    Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial

    Ann Emerg Med

    (1998)
  • SF Lanes et al.

    The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials

    Chest

    (1998)
  • Y Nakano et al.

    Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with spacer device in adults with acute severe asthma

    J Allergy Clin Immunol

    (2000)
  • J Benito Fernández et al.

    Eficacia de la administración precoz de bromuro de ipratropio nebulizado en niños con crisis asmática

    Ann Esp Pediatr

    (2000)
  • RM Higgins et al.

    Should ipratropium bromide be added to β-agonists in the treatment of acute severe asthma?

    Chest

    (1988)
  • WTA Watson et al.

    Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma

    J Allergy Clin Immunol

    (1988)
  • M Owens et al.

    Nebulized atropine sulfate in the treatment of acute asthma

    Chest

    (1991)
  • RK Cydulka et al.

    Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma

    Ann Emerg Med

    (1994)
  • JP Karpel et al.

    A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma

    Chest

    (1996)
  • JM FitzGerald et al.

    The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs. nebulized adrenergic bronchodilator alone in acute asthma

    Chest

    (1997)
  • FM Ducharme et al.

    Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma

    J Pediatr

    (1998)
  • EJ Weber et al.

    Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm: a randomized controlled trial

    Chest

    (1999)
  • PJ Barnes et al.

    Muscarinic receptor subtypes in the airways

    Trends Pharmacol Sci

    (1988)
  • PJ Barnes

    Muscarinic receptor subtypes in airways

    Life Sci

    (1993)
  • AD Fryer et al.

    Effect of inflammatory cell mediators on M2 muscarinic receptors in the lungs

    Life Sci

    (1993)
  • DW Cugell

    Clinical pharmacology and toxicology of ipratropium bromide

    Am J Med

    (1986)
  • C Rodrigo et al.

    Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma

    Chest

    (1998)
  • BH Rowe et al.

    Nebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department?

    Ann Emerg Med

    (1999)
  • RG Stoodley et al.

    The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials

    Ann Emerg Med

    (1999)
  • G Rodrigo et al.

    Ipratropium bromide in acute asthma: small beneficial effects [letter]?

    Chest

    (1999)
  • R Silverman

    Ipratropium bromide in emergency management of acute asthma exacerbation [letter]

    Ann Emerg Med

    (2000)
  • G Rodrigo et al.

    A meta-analysis of the effects of ipratropium bromide in adults with acute asthma

    Am J Med

    (1999)
  • DL Bowton et al.

    Substitution of metered dose inhalers for hand held nebulizers: success and cost savings in a large acute care hospital

    Chest

    (1992)
  • B Gandevia

    Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders

    Postgrad Med J

    (1975)
  • N Gross et al.

    Anticholinergic, antimuscarinic bronchodilators

    Am Rev Respir Dis

    (1984)
  • I Ziment et al.

    Anticholinergic agents

    Clin Chest Med

    (1986)
  • R Weber

    Role of anticholinergics in asthma

    Ann Allergy

    (1990)
  • Cited by (0)

    View full text